ANEW Medical Partners With Okinawa Research Center to Develop Longevity Drugs
ANEW Medical (WENA) said Thursday it has partnered with researchers at Japan's Okinawa Research Center for Longevity Science for the development of its Klotho gene therapy in reducing age-related diseases.
Okinawa is among a set of global "Blue Zones" with high numbers of people who live to high ages and remain in good health.
ANEW said preliminary data suggests that the alpha-Klotho version of the human Klotho gene and its secreted alpha-Klotho protein isoform may contribute to long lifespans and protection against diseases such as Alzheimer's Disease. The company is developing a portfolio of therapies targeting the gene.
Price: 3.4200, Change: -0.20, Percent Change: -5.52
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。